We have a diverse pipeline of innovative products and investigational drugs in various therapeutic areas.
We are working on our own internal product candidates and have interests in a range of partner programmes.
GLYCOMIR' s next generation advanced wound care products have been documented in clinical trials to improve the overall quality of wound care significantly.
The GLYCOMIR Intra Venous & Catheter Line Fixation products provides a cutting-edge solution designed to prevent and avoid infections associated with intravenous and catheter lines.
The UNLEASH™ medical device technology is part of a non-drug line of immunotherapy research with potential advantages over drug therapies.